Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut Sterilisation in Alcoholic Hepatitis
NCT03157388Completed
- Sponsor
- Aarhus University
- Start
- Jun 2017
- Primary completion
- Jun 2018
- Modality
- Nanoparticles, Implantable Devices, Cyclic Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of vancomycin, gentamicin and meropenem in alcoholic hepatitis (AH), sponsored by Aarhus University. Primary endpoint: Macrophage activation cd163 at 1 year. Started Jun 2017; status: completed.
02
Drugs
vancomycingentamicinmeropenem
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT03157388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03157388.